Gum disease treatment may alter Bone-Related markers, study finds

NCT ID NCT07475013

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how a standard deep-cleaning procedure called scaling and root planing affects certain proteins in the blood and gum fluid of people with advanced gum disease. Researchers will compare 28 patients with stage 3 periodontitis to 28 healthy individuals, measuring markers like GPNMB, TGF-β1, RANKL, and osteoprotegerin before and after treatment. The goal is to understand how these markers change and what they might mean for bone health and healing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Scaling and Root Planing (SRP)
What this could lead to
If successful, this study could reveal how standard gum treatment affects key markers linked to bone health and healing, potentially guiding future therapies for periodontitis.
What could go wrong
This is a small, early-stage observational study with only 56 participants. It measures biological markers, not direct health outcomes, so results may not lead to new treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIODONTITIS (STAGE 3) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Camurati-Engelmann Syndrome periodontitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği Fakültesi

    Ankara, 06010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.